Multidisciplinary experts consensus on diagnosis and treatment of precancerous lesions of hepatocellular carcinoma (2023 version).
10.3760/cma.j.cn501113-20231010-00136
- VernacularTitle:肝细胞癌癌前病变诊断和治疗多学科专家共识（2023版）
- Collective Name:Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association;;Editorial Board of Chinese Journal of Hepatology
- Publication Type:Journal Article
- Keywords:
Consensus;
Diagnosis;
Hepatocellular carcinoma;
Multidisciplinary team;
Precancerous lesions;
Treatment
- MeSH:
Humans;
Carcinoma, Hepatocellular/therapy*;
Consensus;
Liver Neoplasms/therapy*;
Precancerous Conditions/therapy*
- From:
Chinese Journal of Hepatology
2023;31(12):1250-1261
- CountryChina
- Language:Chinese
-
Abstract:
According to the latest statistical data, the incidence and mortality rate of hepatocellular carcinoma in China are still on the rise, posing a major threat to the health of the Chinese population. The occurrence is closely related to the formation of precancerous lesions in the liver. The clinical and basic research on precancerous lesions of hepatocellular carcinoma has developed rapidly, and the concepts and specific techniques for diagnosis and treatment have also undergone new changes and advancements. Therefore, based on the first version in 2020, this consensus has organized multidisciplinary experts to compile and improve a new version by integrating the latest progress in their respective professional fields at home and abroad. It aims to enhance clinicians' understanding of precancerous lesions of hepatocellular carcinoma standardize the pathology, imaging, and molecular diagnostic criteria, broaden early screening methods, formulate scientifically rational treatment plans, and help promote the advancement of diagnosis and treatment strategies and to enhance the overall 5-year survival rate of patients with hepatocellular carcinoma.
